PATENT CLAIM ANALYSIS

Application Number: 16358013
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "04400R"]

Abstract:
Provided are therapeutic agents such as double-stranded nucleic acids, termed oligonucleotide decoys, pharmaceutical compositions comprising the same, and related methods of modulating nociceptive signaling, for instance, to prevent and/or treat pain.

Claim (Index 1):
A population of oligonucleotide decoys, the oligonucleotide decoys comprising a combination of at least two transcription factor binding sites, wherein each transcription factor binding site binds to at least one transcription factor selected from the group consisting of KLF6, KLF9, and KLF15, wherein\n the population of oligonucleotide decoys provides a transcription factor binding ratio of KLF15/KLF9 equal to or less than about 0.8 or equal to or higher than about 1.0 in a standard ELISA assay; or the population of oligonucleotide decoys provides a total transcription factor binding capacity to KLF6 and KLF9 that is equal to or higher than an optical density value of about 0.2 OD 450  in a standard ELISA assay.

Metadata:
- Claim Count in Document: 46.0
- Percentile: 99.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15504191', '13048793', '13316321', '14258927', '12119435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7301358396955407
- 35 USC 102 Novelty (BERT): 0.7742624467084358
- Combined Prediction Score: 0.7345485003968303
- Mean Citation Score: 484.57665599999984
- Max Citation Score: 1020.33746
- Similarity Product: 900.405533439939

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test